About Vectura

We are a specialist inhalation CDMO that provides innovative inhaled drug development solutions to help customers bring their medicines to patients.

Our Science

See how our scientific innovation and expertise can support your inhaled development programme

Find out more

Product development

Tailored inhalation services for you

Track record

Choose a partner to help you succeed

News

Shortlisted for Best Sustainability Reporting: Healthcare

15/06/2021

Vectura is proud to announce that we have been shortlisted for Best Sustainability Reporting: Healthcare at the ESG Reporting Awards...

Vectura announces completion of management buy-out of Lyon oral subsidiary, Skyepharma Production SAS

10/06/2021

Vectura Group plc, an industry-leading specialist inhalation CDMO, today announces the successful completion of a management buy-out of its oral...

Environmental, Social and Governance (ESG) Strategy

Know more about our commitment to creating long-term growth by embedding sustainability in all our business practices.

DOWNLOAD ESG REPORT